comparemela.com
Home
Live Updates
Lupin : December 27, 2023 Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Suspension, 0.2% -December 27, 2023 at 03:42 pm EST : comparemela.com
Lupin : December 27, 2023 Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Suspension, 0.2% -December 27, 2023 at 03:42 pm EST
Mumbai, Baltimore, December 27, 2023: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its...
Related Keywords
Mumbai ,
Maharashtra ,
India ,
United States ,
South Africa ,
Asia Pacific ,
Shweta Munjal ,
Linkedin ,
Facebook ,
Bausch Lomb Inc ,
Lupin Limited ,
Drug Administration ,
Biotechnology Pharmaceuticals ,
Twitter ,
Corporate Communications ,
United States Food ,
Abbreviated New Drug Application ,
Loteprednol Etabonate Ophthalmic Suspension ,
Ophthalmic Suspension ,
Etabonate Ophthalmic Suspension ,
Latin America ,
Middle East ,
Great Place ,
Global Head ,
Markets ,
comparemela.com © 2020. All Rights Reserved.